Standard angiogenic factors like VEGF primarily accelerate growth without this built-in regulatory mechanism
Risk factors for endometrial cancer include obesity, diabetes, high blood pressure, never having been pregnant, and taking estrogen without progesterone
PDA has a very similar molecular structure to BPC-157
This is the mechanism behind the "copper uglies" that some users experience when they start too fast: if breakdown temporarily outpaces rebuilding, skin can look temporarily loose
BPC-157: More localized, especially in the GI tract and connective tissue TB-500: Broader systemic effects, influencing cell migration and circulation In some cases, both may be considered together (bpc157 and tb500) as complementary, though decisions must be individualized and physician-guided
The Croatian Phase I and II clinical trials for inflammatory bowel disease conducted in the 1990s by pharmaceutical company Pliva claimed safety with no significant toxicity, though complete peer-reviewed data never appeared in scientific literature beyond conference abstracts
